Cargando…

Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study

INTRODUCTION: Knowledge about the influence of current neuroprotective interventions on prognostic markers after survival from cardiac arrest is lacking. This study aimed to investigate the effects of mild therapeutic hypothermia on the release of the astroglial protein S-100 after cardiopulmonary r...

Descripción completa

Detalles Bibliográficos
Autores principales: Derwall, Matthias, Stoppe, Christian, Brücken, David, Rossaint, Rolf, Fries, Michael
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689505/
https://www.ncbi.nlm.nih.gov/pubmed/19368739
http://dx.doi.org/10.1186/cc7785
_version_ 1782167806887854080
author Derwall, Matthias
Stoppe, Christian
Brücken, David
Rossaint, Rolf
Fries, Michael
author_facet Derwall, Matthias
Stoppe, Christian
Brücken, David
Rossaint, Rolf
Fries, Michael
author_sort Derwall, Matthias
collection PubMed
description INTRODUCTION: Knowledge about the influence of current neuroprotective interventions on prognostic markers after survival from cardiac arrest is lacking. This study aimed to investigate the effects of mild therapeutic hypothermia on the release of the astroglial protein S-100 after cardiopulmonary resuscitation (CPR) in survivors of out-of-hospital cardiac arrest. METHODS: This was a prospective, observational study performed during a two-year period, involving medical emergency services and five collaborating hospitals at the city of Aachen, Germany. Sixty-eight subjects were enrolled by the emergency physician on duty by taking blood samples after successful attempts at resuscitation with return of spontaneous circulation (ROSC), followed by samples at 6, 12, 24, 72 and 120 hours post ROSC by the appropriate intensive care unit staff. Depending on the decision of the attending physician, subjects were cooled down to 33°C (n = 37) for 24 hours or were held at 37°C (n = 31). Patients were tracked for estimating mortality and gross neurological outcome for 14 days. RESULTS: S-100 levels in patients not receiving mild therapeutic hypothermia (normothermia (NT)) showed equivalent numbers as compared with cooled patients (mild therapeutic hypothermia (MTH)) on baseline (NT = 1.38 μg/l versus MTH = 1.30 μg/l; P = 0.886). S-100 levels on baseline were significantly lower in patients with a good neurological outcome at 14 days after the event in comparison to their peers with adverse outcome (P = 0.014). Although the difference in S-100 levels of MTH patients with adverse or favourable neurological outcome reached statistical significance, it did not in NT patients. CONCLUSIONS: Although the predictive power of S-100 levels were best on admission but not at later time points, MTH had no influence on S-100 serum levels in survivors of non-traumatic out-of-hospital cardiac arrest in the particular setting of this investigation.
format Text
id pubmed-2689505
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26895052009-06-02 Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study Derwall, Matthias Stoppe, Christian Brücken, David Rossaint, Rolf Fries, Michael Crit Care Research INTRODUCTION: Knowledge about the influence of current neuroprotective interventions on prognostic markers after survival from cardiac arrest is lacking. This study aimed to investigate the effects of mild therapeutic hypothermia on the release of the astroglial protein S-100 after cardiopulmonary resuscitation (CPR) in survivors of out-of-hospital cardiac arrest. METHODS: This was a prospective, observational study performed during a two-year period, involving medical emergency services and five collaborating hospitals at the city of Aachen, Germany. Sixty-eight subjects were enrolled by the emergency physician on duty by taking blood samples after successful attempts at resuscitation with return of spontaneous circulation (ROSC), followed by samples at 6, 12, 24, 72 and 120 hours post ROSC by the appropriate intensive care unit staff. Depending on the decision of the attending physician, subjects were cooled down to 33°C (n = 37) for 24 hours or were held at 37°C (n = 31). Patients were tracked for estimating mortality and gross neurological outcome for 14 days. RESULTS: S-100 levels in patients not receiving mild therapeutic hypothermia (normothermia (NT)) showed equivalent numbers as compared with cooled patients (mild therapeutic hypothermia (MTH)) on baseline (NT = 1.38 μg/l versus MTH = 1.30 μg/l; P = 0.886). S-100 levels on baseline were significantly lower in patients with a good neurological outcome at 14 days after the event in comparison to their peers with adverse outcome (P = 0.014). Although the difference in S-100 levels of MTH patients with adverse or favourable neurological outcome reached statistical significance, it did not in NT patients. CONCLUSIONS: Although the predictive power of S-100 levels were best on admission but not at later time points, MTH had no influence on S-100 serum levels in survivors of non-traumatic out-of-hospital cardiac arrest in the particular setting of this investigation. BioMed Central 2009 2009-04-16 /pmc/articles/PMC2689505/ /pubmed/19368739 http://dx.doi.org/10.1186/cc7785 Text en Copyright © 2009 Derwall et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Derwall, Matthias
Stoppe, Christian
Brücken, David
Rossaint, Rolf
Fries, Michael
Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
title Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
title_full Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
title_fullStr Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
title_full_unstemmed Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
title_short Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
title_sort changes in s-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689505/
https://www.ncbi.nlm.nih.gov/pubmed/19368739
http://dx.doi.org/10.1186/cc7785
work_keys_str_mv AT derwallmatthias changesins100proteinserumlevelsinsurvivorsofoutofhospitalcardiacarresttreatedwithmildtherapeutichypothermiaaprospectiveobservationalstudy
AT stoppechristian changesins100proteinserumlevelsinsurvivorsofoutofhospitalcardiacarresttreatedwithmildtherapeutichypothermiaaprospectiveobservationalstudy
AT bruckendavid changesins100proteinserumlevelsinsurvivorsofoutofhospitalcardiacarresttreatedwithmildtherapeutichypothermiaaprospectiveobservationalstudy
AT rossaintrolf changesins100proteinserumlevelsinsurvivorsofoutofhospitalcardiacarresttreatedwithmildtherapeutichypothermiaaprospectiveobservationalstudy
AT friesmichael changesins100proteinserumlevelsinsurvivorsofoutofhospitalcardiacarresttreatedwithmildtherapeutichypothermiaaprospectiveobservationalstudy